Mark Densel
Corporate Officer/Principal chez EFFECTOR THERAPEUTICS, INC.
Profil
Mark Densel is currently working as the Vice President-Development Operations at eFFECTOR Therapeutics, Inc. Previously, he held the position of Senior Director-Project Management at Ardea Biosciences, Inc. and Vice President-Project Management at La Jolla Pharmaceutical Co. Mr. Densel completed his undergraduate degree at Ball State University (Indiana).
Postes actifs de Mark Densel
| Sociétés | Poste | Début |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2018 |
Anciens postes connus de Mark Densel
| Sociétés | Poste | Fin |
|---|---|---|
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - |
Formation de Mark Densel
| Ball State University (Indiana) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EFFECTOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
